Impact of multiplex PCR respiratory panels on antimicrobial stewardship and clinical outcomes in hospitalized adults with pneumonia: a systematic review and meta-analysis
Infection · 09.11.2026
DOI: 10.1007/s15010-026-03045-w ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Infection, online erschienen am 09.11.2026. Verfasst von Chaehyun Ahn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacy Practice and Administration, University of Missouri-Kansas City School of Pharmacy, 2464 Charlotte Street, Kansas City, MO, 6410…. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Inadequate empiric antimicrobial therapy increases mortality and healthcare costs. Rapid multiplex PCR respiratory panels can provide faster and more sensitive pathogen detection than conventional culture-based methods; however, interpretation may be limited by detection of colonizing organisms and resistance genes that do not always correspond to phenotypic resistance. Their impact on clinical outcomes and antimicrobial stewardship remains uncertain due to heterogeneous studies and clinical implementation strategies. This systematic review and meta-analysis evaluates the clinical value of these panels in hospitalized adults with pneumonia. METHODS: Following PRISMA guidelines, we searched MEDLINE, EMBASE, and the Cochrane Library through October 15, 2025, for randomized controlled trials (RCTs) comparing multiplex PCR-guided therapy with standard microbiological testing. The primary outcome was total antibiotic duration. Secondary outcomes included incidence of targeted/appropriate antimicrobial therapy, length of hospitalization, 1-month mortality, 1-month hospital readmission, and antibiotic-related adverse events. FINDINGS: The analysis included six RCTs involving 2,087 patients. Multiplex PCR-guided therapy showed a modest but non-significant reduction in antibiotic duration (MD -0.74 days; 95% CI: -2.28 to 0.79; p = 0.22). No statistically significant differences were found for secondary outcomes, including targeted or appropriate antimicrobial therapy, length of hospitalization, antibiotic-related adverse events, 1-month mortality, or 1-month hospital readmissions. CONCLUSIONS: Multiplex PCR panels provide rapid diagnostic data, but the available randomized evidence provides insufficient evidence that their implementation reduces total antibiotic duration or downstream clinical outcomes in patients with pneumonia. These findings do not exclude potential benefits in earlier antimicrobial optimization, which appear to depend on clinical context and implementation strategy.
Autor:innen und Institutionen
- Division of Pharmacy Practice and Administration, University of Missouri-Kansas City School of Pharmacy, 2464 Charlotte Street, Kansas City, MO, 64108, USA.
- Division of Pharmacy Practice and Administration, University of Missouri-Kansas City School of Pharmacy, 818 Lewis Hall, Columba, MO, 65211, USA.
- Division of Pharmacy Practice and Administration, University of Missouri-Kansas City School of Pharmacy, 2464 Charlotte Street, Kansas City, MO, 64108, USA. sperrym@umkc.edu.
Zitieren
APA
Ahn, C., Chanliongco, A. N., Smith, A. J., Steuber, T. D., & Sperry, M. (2026). Impact of multiplex PCR respiratory panels on antimicrobial stewardship and clinical outcomes in hospitalized adults with pneumonia: a systematic review and meta-analysis. Infection. https://doi.org/10.1007/s15010-026-03045-w
Vancouver
Ahn C, Chanliongco AN, Smith AJ, Steuber TD, Sperry M. Impact of multiplex PCR respiratory panels on antimicrobial stewardship and clinical outcomes in hospitalized adults with pneumonia: a systematic review and meta-analysis. Infection. 2026. doi:10.1007/s15010-026-03045-w
BibTeX
@article{Ahn2026,
author = {Ahn, Chaehyun and Chanliongco, Adam N and Smith, Andrew J and Steuber, Taylor D and Sperry, Morgan},
title = {Impact of multiplex PCR respiratory panels on antimicrobial stewardship and clinical outcomes in hospitalized adults with pneumonia: a systematic review and meta-analysis},
journal = {Infection},
year = {2026},
doi = {10.1007/s15010-026-03045-w}
}
EUVIMED